NCT06053021View on ClinicalTrials.gov

Antiplatelet Therapy for AIS Patients With Thrombocytopenia

NARecruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

January 1, 2026

Conditions
Acute Ischemic StrokeThrombocytopenia
Interventions
DRUG

aspirin, clopidogrel, cilostazol, and dipyridamole

Participants will be prescribed antiplatelet agents including aspirin, clopidogrel, cilostazol, and dipyridamole.

Trial Locations (1)

Unknown

RECRUITING

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER